Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Associated With Lansoprazole Use in Patients Receiving Ceftriaxone
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Ceftriaxone and the Risk of Ventricular Arrhythmia, Cardiac Arrest, and Death Among Patients Receiving Lansoprazole
JAMA Netw Open 2023 Oct 02;6(10)e2339893, AD Bai, A Wilkinson, A Almufleh, M Rai, F Razak, AA Verma, S SrivastavaFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.